Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
AMR Phoenix, Phoenix, Arizona AMR Fort Myers, Fort Myers, Florida AMR Lexington, Lexington, Kentucky AMR Kansas City, Kansas City, Missouri Knoxville, Knoxville, Tennessee